Related Experiment Video
Updated: Aug 6, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter
Abstract:
ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) -1, -4 and -5 proteases have been identified in the CNS at the mRNA level. These glutamyl endopeptidases, inhibited by tissue inhibitor of metalloproteinases (TIMP)-3, are key enzymes in the degradation of the aggregating chondroitin sulphate proteoglycans (CSPGs), and may therefore play a role in CNS extracellular matrix (ECM) changes in multiple sclerosis (MS). We have investigated ADAMTS and TIMP-3 expression in normal and MS CNS white matter by real-time RT-PCR, western blotting and immunohistochemistry. We report for the first time the presence of ADAMTS-1, -4 and -5 in normal and MS white matter. Levels of ADAMTS-1 and -5 mRNA were decreased in MS compared to normal tissue, with no significant change in ADAMTS-4 mRNA levels. Protein levels of ADAMTS-4 were significantly higher in MS tissue compared to normal tissue. Immunohistochemical studies demonstrated that ADAMTS-4 was associated predominantly with astrocytes with increased expression within MS lesions. TIMP-3 mRNA was significantly decreased in MS compared to controls. These studies suggest a role for ADAMTS-4 in the pathogenesis of MS. Further studies on the activity of ADAMTS-4 will enable a better understanding of its role in the turnover of the ECM of white matter in MS.
Insights
Researchers found increased levels of ADAMTS-4 protein in multiple sclerosis (MS) brain tissue, suggesting this enzyme may contribute to MS pathogenesis by affecting the central nervous system extracellular matrix.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- ADAMTS proteases degrade chondroitin sulphate proteoglycans (CSPGs) in the central nervous system (CNS).
- CSPGs are key components of the CNS extracellular matrix (ECM).
- ECM changes are implicated in the pathogenesis of multiple sclerosis (MS).
Purpose of the Study:
- To investigate the expression of ADAMTS-1, -4, -5, and TIMP-3 in normal and MS CNS white matter.
- To determine the role of these proteins in the pathogenesis of MS.
Main Methods:
- Real-time RT-PCR to quantify mRNA levels.
- Western blotting to assess protein levels.
- Immunohistochemistry to localize protein expression in CNS tissue.
Main Results:
- ADAMTS-1 and -5 mRNA levels were decreased in MS white matter compared to normal tissue.
- ADAMTS-4 mRNA levels showed no significant change, but protein levels were significantly higher in MS tissue.
- ADAMTS-4 was predominantly associated with astrocytes and showed increased expression in MS lesions.
- TIMP-3 mRNA levels were significantly decreased in MS tissue.
Conclusions:
- ADAMTS-4 expression is altered in MS, with increased protein levels in affected white matter.
- The findings suggest a potential role for ADAMTS-4 in the pathogenesis of MS.
- Further research into ADAMTS-4 activity is needed to understand its role in white matter ECM turnover in MS.
